You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 118 No. 6, June 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Commentary
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Ophthalmology, Other
 •Alert me on articles by topic

Hemangiomas

Arch Ophthalmol. 2000;118(6):835-836.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

NEW ENGLAND JOURNAL OF MEDICINE

Hemangiomas in Children

Beth A. Drolet, MD; Nancy B. Esterly, MD; Ilona J. Frieden, MD

Hemangiomas are the most common soft-tissue tumors of infancy, occurring in approximately 5 to 10 percent of one-year-old children. Despite the frequency of these tumors, their pathogenesis is not completely understood, and the best approach to their management remains controversial. Research on angiogenesis, an improved knowledge of the classification of the vascular anomalies of infancy, advances in imaging techniques, recently identified complications, and new therapeutic approaches, such as treatment with interferon and lasers, have altered our understanding of this common childhood problem and the way we approach it.

N Engl J Med 1999:341;173-181

Reprints: Beth A. Drolet, MD, Pediatric Dermatology, Medical College of Wisconsin, Froedert East, 9200 W Wisconsin Ave, Milwaukee, WI 53226 (e-mail: drolet@post.its.mcw.edu).

HEMANGIOMAS ARE one of the most common tumors of infancy.1-2 Approximately 55% are present . . . [Full Text of this Article]

Burton J. Kushner, MD
Madison, Wis



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Intraorbital Injection of Triamcinolone Acetonide in Patients With Idiopathic Orbital Inflammation
Leibovitch et al.
Arch Ophthalmol 2007;125:1647-1651.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.